Latest AI and machine learning research in skin cancer for healthcare professionals.
BACKGROUND: Patients with gastric cancer respond poorly to immunotherapy. There are still unknowns a...
In this work, we present the potential of Fourier transform infrared (FTIR) microspectroscopy to com...
OBJECTIVE: Significant advancements have been made in hepatocellular carcinoma (HCC) therapeutics, s...
Breast cancer, a highly formidable and diverse malignancy predominantly affecting women globally, po...
This study offers a detailed exploration of lung adenocarcinoma (LUAD), addressing its heterogeneity...
The mortality and therapeutic failure in cutaneous melanoma (CM) are mainly caused by wide metastasi...
T cells have the ability to eliminate infected and cancer cells and play an essential role in cancer...
The histopathological classification of melanocytic tumours with spitzoid features remains a challen...
The prognosis of lung adenocarcinoma (LUAD) is generally poor. Immunotherapy has emerged as a promis...
BACKGROUND: Establishment of a reliable prognostic model and identification of novel biomarkers are ...
Clear cell renal carcinoma (ccRCC), the most common subtype of renal cell carcinoma, has the high he...
Immune checkpoint therapy (ICT) has greatly improved the survival of cancer patients in the past few...
Early identification of safe and efficacious disease targets is crucial to alleviating the tremendou...
Accurately predicting tumor T-cell antigen (TTCA) sequences is a crucial task in the development of ...
Machine-learning algorithms have the potential to revolutionise diagnostic and prognostic tasks in h...
PURPOSE: The dose deposited outside of the treatment field during external photon beam radiation the...
Exhausted T cells are a key component of immune cells that play a crucial role in the immune respons...
Neoantigens are tumor-derived peptides and are biomarkers that can predict prognosis related to immu...
Immunotherapy plays a key role in cancer treatment, however, responses are limited to a small number...
Neoadjuvant chemoimmunotherapy has revolutionized the therapeutic strategy for non-small cell lung c...